Indexed in Journament
Current Pharmaceutical Letters And Reviews
ISSN 3049-222X· EN
Login or register to claim ownership or editorship of this journal.
42.7
050100
The Journament Score is computed from platform statistics — reader engagement,
accessibility, publication timeliness, keyword breadth, community impact and content
distribution — into a single 0–100 figure, recalculated as new articles and metadata
are indexed. Dimensions that cannot be measured for this journal are excluded rather
than estimated. It is independent of the paid AI Quality Analysis, which never
affects this score or the ranking.
Full methodology →
AI Quality Analysis
44.2 / 100
About This Journal
Current Pharmaceutical Letters And Reviews (CPLR) (ISSN 3049-222X) is a top open-access journal that reviews and publishes research in clinical and pre-clinical fields. We accept various types of articles, such as Research Papers, Reviews, Editorials, and Communications. Our main goal is to share detailed experimental and theoretical research to help others reproduce the results.
One of our unique features is that we also welcome studies with important negative results. While many journals prefer positive outcomes, we understand that negative data is crucial too. By publishing these findings, we help researchers share their results, avoid repeating the same experiments, and ensure that valuable information is not ignored. This way, we aim to provide a fuller understanding of clinical research.
| Short Name | Cur Pha Let Rev |
|---|---|
| Abbreviated Name | CPLR |
| ISSN | 3049-222X |
| URL | https://cplr.in/index.php/files |
| Author Instructions | https://cplr.in/index.php/files/author |
Quality Profile
11 of 12 dimensions measured
This journal
Average of scored journals
Platform statistics — the free Journament Score
AI Quality Analysis — separate paid product, ranks nothing
1 of the 12 dimensions could not be measured for this journal. They are left as gaps in the shape rather than plotted as zero.
Show the numbers
| Dimension | This journal | Corpus average |
|---|---|---|
| Engagement | 30.7 | 30.3 |
| Accessibility | 45.0 | 18.3 |
| Timeliness | 60.0 | 12.6 |
| Diversity | — | 27.3 |
| Innovation | 49.0 | 28.9 |
| Community Impact | 10.7 | 9.7 |
| Content Distribution | 57.8 | 88.5 |
| Content Quality | 55.0 | 55.5 |
| Ethics & Transparency | 40.0 | 40.2 |
| Editorial Standards | 20.0 | 33.4 |
| Publication Regularity | 75.0 | 53.2 |
| Geographic Reach | 25.0 | 30.8 |
Publications Per Year
Articles (18)
2025
, pp. 28-36
70 views
Abstract
2025
Vol. 2
, No. 2
, pp. 48-55
69 views
Abstract
2024
Vol. 1
, No. 1
, pp. 11-24
67 views
Abstract
2025
, pp. 09-18
65 views
Abstract
2025
, pp. 01-08
64 views
Abstract
2024
Vol. 1
, No. 1
, pp. 44-52
63 views
Abstract
2025
Vol. 2
, No. 2
, pp. 01-13
62 views
Abstract
2025
, pp. 19-27
60 views
Abstract
2025
Vol. 2
, No. 2
, pp. 14-40
59 views
Abstract
2025
Vol. 2
, No. 2
, pp. 41-47
55 views
Abstract
2025
, pp. 28-36
70 views
Abstract
2025
, pp. 19-27
60 views
Abstract
2025
, pp. 09-18
65 views
Abstract
2025
, pp. 01-08
64 views
Abstract
2025
Vol. 2
, No. 2
, pp. 41-47
55 views
Abstract
2025
Vol. 2
, No. 2
, pp. 48-55
69 views
Abstract
2025
Vol. 2
, No. 2
, pp. 14-40
59 views
Abstract
2025
Vol. 2
, No. 2
, pp. 01-13
62 views
Abstract
2024
Vol. 1
, No. 1
, pp. 78-87
18 views
Abstract
2024
, pp. 88-94
19 views
Abstract